Analysis of the activity and safety of weekly low‐dose bevacizumab‐based regimens in heavily pretreated patients with metastatic breast cancer

BACKGROUND: Currently, there are no standard regimens for metastatic breast cancer patients (MBC) who have failed ≥ 3 chemotherapy treatments. The aim of this study was to assess whether weekly low‐dose bevacizumab‐based regimens were well tolerated and would improve efficacy in MBC patients who had...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Thorac Cancer
Main Authors: Zhai, Xiaoyu, Hong, Ruoxi, Fan, Ying, Yuan, Peng, Wang, Jiayu, Sang, Die, Chen, Junlin, Zhao, Chunying, Ou, Kaiping, Ma, Fei, Xu, Binghe
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons Australia, Ltd 2018
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5928366/
https://ncbi.nlm.nih.gov/pubmed/29575760
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12627
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados